HJ2-16584-70953
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 605 / IL
- Registered
- 2021-08-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
ULV-30307-85685
Child or adolescent in my care · Female · 2022-07-02
Timeline
-
2021-08-30
Registered in v-safe
-
2021-09-03
Dose 1 — Pfizer-BioNTech
-
2021-09-03
Health check-in — day 0, dose 1Feeling: Good · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-09-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2021-09-05
- 2021-09-06
-
2021-09-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-09-08
- 2021-09-09
- 2021-09-10
- 2021-09-17
-
2021-09-24
Dose 2 — Pfizer-BioNTech
- 2021-09-24
-
2021-09-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-12-24
-
2022-02-26
Dose 3 — Pfizer-BioNTech
- 2022-02-26
-
2022-02-27
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-02-28
- 2022-03-01
-
2022-03-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2022-03-03
- 2022-03-04
- 2022-03-05
- 2022-03-13
- 2022-03-19
-
2022-03-26
Survey response — day 28, dose 3MedDRA: Lower respiratory tract infection — Feeling: GoodFree text: Chest coldMedDRA releases: 2024-11 · check-in free text available
- 2022-04-02
- 2022-04-09
-
2022-05-28
Survey response — 3 months, dose 3MedDRA: Cholecystectomy, Cholelithiasis — Feeling: Fair · Be unable to work or attend schoolFree text: Gallstones-gallbladder removalMedDRA releases: 2024-11 · check-in free text available
- 2022-08-27
- 2023-02-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-03 | Pfizer-BioNTech | No |
| 2 | 2021-09-24 | Pfizer-BioNTech | No |
| 3 | 2022-02-26 | Pfizer-BioNTech | No |
Free text
Release 11 — day 28, dose 3
Symptoms: Chest cold
Release 11 — 3 months, dose 3
Symptoms: Gallstones-gallbladder removal
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholecystectomy | · | · | ✓ |
| SD | Cholelithiasis | · | · | ✓ |
| SD | Lower respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release